A bit about me
Malcolm is passionate about engaging with stakeholders to improve the patient access for innovative treatments
Career highlights
Malcolm joined MAP in July 2021. He has experience across both policy and market access. Malcolm’s work spans UK and EU markets, where he collaborates with patient advocacy groups, industry stakeholders, and policymakers. Malcolm has led multiple projects to develop the HTA policy environment in the UK, particularly around rare disease.
Malcolm has developed a range of policy documents on improving access to medicines in the UK. Additionally he has
Expertise
- Stakeholder engagement
- Policy research
- Implementation of EU HTA
